1. Comparisons of tetrachloro(d,l-trans)1,2-diaminocyclohexaneplatinum(IV) biotransformations in the plasma of Fischer 344 rats at therapeutic and toxic doses

   • Patrick F. Carfagna
   • Allen Poma
   • Stephen G. Chaney

   Original Articles Pages: 335 - 341

2. Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide

   • Lincoln L. H. Tsang
   • Charmaine P. Quarterman
   • John A. Slack

   Original Articles Pages: 342 - 346

3. Intratumoural administration of cisplatin in slow-release devices: II. pharmacokinetics and intratumoural distribution

   • Marc J. M. Deurloo
   • Wim Kop
   • Adrian C. Begg

   Original Articles Pages: 347 - 353

4. Instability of the anticancer agent etoposide under in vitro culture conditions

   • Robert M. Mader
   • Günther G. Steger
   • Christian Dittrich

   Original Articles Pages: 354 - 360

5. High-dose 1,2,4-triglycidylurazol given in regimens preparatory to bone marrow transplantation

   • Dietrich W. Beelen
   • Rudolf B. Schilcher
   • Ulrich W. Schaefer

   Original Articles Pages: 361 - 366

6. Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer

   • Benjamin P. Haynes
   • Michael Jarman
   • R. Charles Coombes

   Original Articles Pages: 367 - 372

7. Pharmacokinetics of thio-TEPA and TEPA in the conventional dose-range and its correlation to myelosuppressive effects

   • Bjørn Hagen

   Original Articles Pages: 373 - 378

8. Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb

   • H. F. Rauschecker
   • H. Foth
   • G. F. Kahl

   Original Articles Pages: 379 - 384

9. Chemotherapy for early-stage gastrointestinal lymphoma

   • Raymond Liang
   • Edmond Chiu
   • S. L. Loke

   Original Articles Pages: 385 - 388

10. Carboplatin/etoposide as first-line chemotherapy in advanced ovarian carcinoma: a pilot study

    • Wolfgang Eiermann
    • Wolf Achterrath
    • Hermann Hepp

    Original Articles Pages: 389 - 393

11. High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II study

    • J. Carmo-Pereira
    • F. O. Costa
    • R. D. Rubens

    Original Articles Pages: 394 - 396

12. Pharmacokinetics of continuous-infusion amsacrine and teniposide for the treatment of relapsed childhood acute nonlymphocytic leukemia

    • William P. Petros
    • John H. Rodman
    • William E. Evans

    Original Articles Pages: 397 - 400

13. Steady-state hydroxyflutamide plasma levels after the administration of two dosage forms of flutamide

    • Rodolfo H. Asade
    • Luis Prizont
    • José Tessler

    Original Articles Pages: 401 - 405

14. Pharmacokinetics of recombinant interferon alpha-C

    • Ofer Merimsky
    • Menachem Rubinstein
    • Samario Chaitchik

    Short Communications Pages: 406 - 408

15. Carboplatin activity in untreated metastatic breast cancer patients — results of a phase II study

    • K. Kolarić
    • D. Vukas

    Short Communications Pages: 409 - 412

16. Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy

    • A. T. McGown
    • D. Murphy
    • B. W. Fox

    Short Communications Pages: 413 - 415

17. Meeting announcement

    Announcement Pages: 416 - 416